Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,061,008
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
6,842,912
-
Shares change
-
+2,165,065
-
Total reported value, excl. options
-
$19,161,000
-
Value change
-
+$6,062,684
-
Number of buys
-
4
-
Number of sells
-
5
-
Price
-
$2.80
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q3 2022
As of 30 Sep 2022 Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 6,842,912 shares of stock of the company.
Largest 10 holders included 22NW, LP, LVW Advisors, LLC, Nantahala Capital Management, LLC, MANGROVE PARTNERS, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, Tower Research Capital LLC (TRC), BlackRock Inc., UBS Group AG, and MORGAN STANLEY.
This table shows 10 institutional shareholders of the security as of 30 Sep 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.